This most recent twist during the Lykos Therapeutics saga threatens A significant overhaul of the company’s approach and direction, with Musk ally and billionaire Trader Antonio Gracias showing to would like to acquire the organization back again towards its nonprofit drug improvement roots and a more Doblinite philosophy.The idea from the cartri